Stock listing
Aardvark Therapeutics, Inc.
Selected listing: AARD · NASDAQ · USD · US
Aardvark Therapeutics, Inc. (NASDAQ:AARD), Health Technology. Latest release Oct 2, 2026: Aardvark Therapeutics Announces Inducement Grant Under Nasdaq…
- Ticker
- NASDAQ:AARD
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Aardvark Therapeutics, Inc.
The company is focused on developing innovative therapeutic solutions. Aardvark Therapeutics aims to address unmet medical needs through its research and development efforts.
Latest news from Aardvark Therapeutics, Inc.
Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 2, 2026
Aardvark Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 11, 2026
Aardvark Therapeutics Plans to Unblind HERO and OLE Data to Inform Path Forward Following FDA Clinical Hold
May 14, 2026
Aardvark Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
May 7, 2026
Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
March 22, 2026
Research Aardvark Therapeutics, Inc.
Aardvark Therapeutics, Inc. company profile
View the public company page for Aardvark Therapeutics, Inc. on 6ix.
Aardvark Therapeutics, Inc. news
Read company news and market updates connected to Aardvark Therapeutics, Inc..
Aardvark Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Aardvark Therapeutics, Inc..